Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-24

FDA Approved: ISONIAZID — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for isoniazid from Teva Pharmaceuticals USA, Inc., confirming regulatory clearance for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISONIAZID (ISONIAZID)

Snippet

SUPPL AP for ISONIAZID (ISONIAZID)